Florida Cancer Specialists & Research Institute Announces Bradley Monk, MD as Medical Director of Late-Phase Clinical Research Program

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Bradley Monk, MD will join the statewide practice as Medical Director of Late-Phase Research, effective January 1, 2024.

Related Keywords

California ,United States ,Arizona ,University Of Arizona ,Florida ,Virginia ,Nathanh Walcker ,Los Angeles ,Lucion Gordan ,Sarah Cannon Research Institute ,National Cancer Institute ,University Of Arizona College Medicine ,University Of California ,Virginiag Piper Cancer Center ,Phase Research ,Drug Development Units ,Florida Cancer Specialists Research Institute ,Florida Cancer Specialists ,Research Institute ,Bradley Monk ,Medical Director ,Late Phase Research ,Executive Officer ,Real World Evidence ,Ernst Wertheim Award ,Cancer Center ,Sarah Cannon Research ,Clinical Scholar Track ,Arizona College ,